ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CRSR
Corsair Gaming, Inc.
CRSR has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CRSR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CRSR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CRSR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $12.28 | — |
| Cheap | 18x | $7.00 | -43% |
| Fair | 30x | $11.35 | -7.5% |
| Current | 32x | $12.28 | — |
| Expensive | 99x | $37.59 | +206% |
Historical ranges are pointers, not guarantees.
CRSR's PE is in its fair range at 32x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CRSR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CRSR, with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CRSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.79 | +107% |
| Q3 2026 | $0.38 | +$0.72 |
| Q2 2026 | $0.31 | +$1.12 |
| Q1 2026 | $0.09 | +$1.02 |
| Q4 2025 | -$0.12 | +$0.83 |
| Q3 2025 | -$0.34 | +$0.62 |
| Q2 2025 | -$0.81 | -$0.38 |
| Q1 2025 | -$0.93 | -$0.79 |
| Q4 2024 | -$0.95 | -$0.92 |
CRSR has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CRSR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CRSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367M | +6.1% |
| Q2 2026 | $314.3M | -1.8% |
| Q1 2026 | $354.5M | -4.1% |
| Q4 2025 | $436.9M | +5.6% |
| Q3 2025 | $345.8M | +14% |
| Q2 2025 | $320.1M | +23% |
| Q1 2025 | $369.8M | +9.6% |
| Q4 2024 | $413.6M | -0.9% |
CRSR's revenue is recovering but still below its 2020 peak: $367M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +1.2 points |
| Q2 2026 | 2.4% | +7.7 points |
| Q1 2026 | 3.9% | +4.5 points |
| Q4 2025 | 6.2% | +4.7 points |
| Q3 2025 | -1.6% | +5.3 points |
| Q2 2025 | -5.3% | +4.2 points |
| Q1 2025 | -0.6% | +2.4 points |
| Q4 2024 | 1.4% | -1.5 points |
CRSR has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CRSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.7M | +$24.6M |
| Q2 2026 | $72.1M | +162% |
| Q1 2026 | $26.1M | +66% |
| Q4 2025 | $32.9M | -39% |
| Q3 2025 | -$41.3M | -290% |
| Q2 2025 | $27.5M | +$48.5M |
| Q1 2025 | $15.7M | +$44.5M |
| Q4 2024 | $54.1M | -1.9% |
CRSR has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CRSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -487K shares |
| 1 year | +2.3% | +2.4M shares |
| 3 years | +5.7% | +5.8M shares |
| 5 years | +8.7% | +8.7M shares |
| Available history | +18% | +16.9M shares |
CRSR has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $962,000 |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -1.3x | Net Cash |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 1.5x | Healthy |
| Q2 2024 | 11.2x | High |
| Q1 2024 | 1.4x | Healthy |
| Q4 2023 | 0.4x | Very low |
| Q3 2023 | 1.3x | Healthy |
CRSR has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CRSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 40.1 | Neutral |
CRSR's weekly RSI is 55 (neutral) and its Stochastic is 40 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CRSR PE vs Technology Sector
| Metric | CRSR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 16% above |
| PE % | 55 | 38 | 17 pts above |
CRSR is trading at 32x earnings, a 16% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CRSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 5.8% below |
| 20 week MA | $12.2 | 1.1% above |
| 50 week MA | $8.83 | 39% above |
| 100 week MA | $8.67 | 42% above |
| 200 week MA | $10.8 | 14% above |
CRSR has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CRSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $36.4 | +111% |
| 2021 | $36.4 | $22.4 | -38% |
| 2022 | $22.4 | $13.7 | -39% |
| 2023 | $13.7 | $14.1 | +2.6% |
| 2024 | $14.1 | $6.55 | -54% |
| 2025 | $6.55 | $6.10 | -6.9% |
| 2026 YTD | $6.10 | $12.3 | +101% |
CRSR has the edge over ASTS on returns for 2026, with the stronger performance.